期刊文献+

文拉法辛缓释片与帕罗西汀治疗抑郁症的对照研究 被引量:8

A control study on Venlafaxine and Paroxetine in the treatment of depression
下载PDF
导出
摘要 目的评估文拉法辛缓释片与帕罗西汀治疗抑郁症的疗效和不良反应。方法将符合CCMD-3诊断标准的61例抑郁症住院和门诊患者,随机分为两组,分别予文拉法辛缓释片和帕罗西汀治疗,疗程8周。用汉密尔顿抑郁量表(HAMD)和不良反应量表(TESS)评定疗效和不良反应。结果文拉法辛缓释片与帕罗西汀治疗抑郁症疗效接近,但前者起效更快,不良反应少于后者。结论文拉法辛缓释片是一种安全、有效的新一代抗抑郁药。 Objective To compare efficacy and side effects between Venlafaxine and Paroxetine in the treatment of depression.Methods 61 inpatients and outpatients with a diagnosis of depression according to CCMD-3 were involved in this study,they were randomly assigned to the Venlafaxine group(n=31)and the paroxetine group(n=30)for 8 weeks.Effects and side reactions were evaluated with HAMD and TESS before and after the treatment.Results Findings indicated that emcacy of Venlafaxine was similar to than of paroxetine,however,Venlafaxine took effect more quickly and its side effects were less than paroxetine.Conclusion Venlafaxine is an effective and safe anti-depressant.
作者 李大年
出处 《中国实用医药》 2011年第34期31-33,共3页 China Practical Medicine
关键词 文拉法辛 帕罗西汀 抑郁症 对照研究 Veulafaxine Paroxetine Depression Control study-
  • 相关文献

参考文献8

二级参考文献12

  • 1Harvey AT, Rudolph RL, Preskom SH. Evidence of the dual mechanism of venlafaxine[ J ]. Arch Gen Psychiatry, 2000,57 ( 5 ) : 503 - 509. 被引量:1
  • 2Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors [ J ]. Br J Psychiatry ,2001,178:234 - 241. 被引量:1
  • 3Garland EJ. Pharmacotherapy of adolescent attention deficit hyperactivity disorder : challengers, choices and caveats [ J ]. J Psychopharmacol, 1998,12:389. 被引量:1
  • 4Hoencamp E, Haffmans J, Dijken WA, et al. Lithium augmentation of venlafaxine : an open - label trial [ J ]. J Clin Psychopharmacol, 2000,20 ( 5 ) :538 - 543. 被引量:1
  • 5Femier IN. Treatment of major depression: improvement enough?[J]. J Clin Psychiatry 1999, (Suppl 6) :10 -14. 被引量:1
  • 6Rudolph RL, Feiger AD, A double - blind, randomized, placebo - controlled trial of once - daily venlafaxine extended release (XR) and fluoxetion for the treatment of depression [ J ]. J Affect Disord 1999,56 : 171 - 181. 被引量:1
  • 7BOLAND E A, GERY M, OSETERLE A, et al. Continuous subcutaneous insulin infufion:a new way to lower risk of severe hypoglycemia improve metabolic conerol,and enhance coping in adolescents with type Ⅰ diabetes[J]. Diabetes Care, 1999, 22(11):1284-1289. 被引量:1
  • 8UNGER J, FREDRICKSON L. A primer on intensive diabetes management and insulin pump therapy[J]. Primary Care Rep,1997,3(1):9-18. 被引量:1
  • 9李冰,王祖新.万拉法新治疗抑郁症的临床验证[J].上海精神医学,1997,9(4):269-272. 被引量:67
  • 10陆林,黄明生,孙学礼,杨彦春,李静,徐楠,季刚.国产万拉法新胶囊Ⅰ期临床耐受性试验[J].上海精神医学,1998,10(4):190-192. 被引量:30

共引文献42

同被引文献60

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部